Cryo-Cell International, Inc.
CCEL
$4.20
-$0.10-2.33%
AMEX
| 08/31/2025 | 05/31/2025 | ||||
|---|---|---|---|---|---|
| Revenue | -1.30% | -0.50% | |||
| Total Other Revenue | -- | -- | |||
| Total Revenue | -1.30% | -0.50% | |||
| Cost of Revenue | -2.97% | -6.45% | |||
| Gross Profit | -0.80% | 1.47% | |||
| SG&A Expenses | -8.96% | -8.20% | |||
| Depreciation & Amortization | -2.31% | -0.94% | |||
| Other Operating Expenses | -- | -- | |||
| Total Operating Expenses | -7.94% | -6.90% | |||
| Operating Income | 27.33% | 41.34% | |||
| Income Before Tax | 106.23% | 7.76% | |||
| Income Tax Expenses | 99.09% | -12.59% | |||
| Earnings from Continuing Operations | 110.62% | 25.77% | |||
| Earnings from Discontinued Operations | -- | -- | |||
| Extraordinary Item & Accounting Change | -- | -- | |||
| Minority Interest in Earnings | -- | -- | |||
| Net Income | 110.62% | 25.77% | |||
| EBIT | 27.33% | 41.34% | |||
| EBITDA | 23.05% | 33.65% | |||
| EPS Basic | 111.36% | 25.71% | |||
| Normalized Basic EPS | 44.99% | 68.88% | |||
| EPS Diluted | 125.00% | 33.33% | |||
| Normalized Diluted EPS | 45.50% | 70.30% | |||
| Average Basic Shares Outstanding | -0.28% | -0.02% | |||
| Average Diluted Shares Outstanding | -0.64% | -0.91% | |||
| Dividend Per Share | -100.00% | -40.00% | |||
| Payout Ratio | -1.00% | -0.52% | |||